PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING
article
OA: closed
CC0
⤵ 83 in-corpus citations
AI-generated summary
Endometrial prostaglandin synthesis was altered in women with dysfunctional uterine bleeding, showing a reduced PGF2 alpha/PGE2 ratio associated with increased blood loss.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The endogenous concentrations of prostaglandins F2 alpha (PGF 2 alpha) and E (PGE) were measured during the luteal phase of the menstrual cycle in the endometrium from 14 women with unexplained menorrhagia (measured menstrual blood loss in excess of 50 ml) and 15 women with normal menses (blood loss 50 ml or less). Although there was no significant difference in the PGF 2 alpha/PGE ratio between the two groups, this ratio was significantly lower in the endometrium from eight of the women whose blood loss exceeded 90 ml (p less than 0.05). There was a significant inverse correlation between the PGF 2 alpha/PGE ratio and blood loss (r = 0.36, p less than 0.025). The synthetic capacity of the endometrium was assessed by incubation of the tissue with 14C arachidonic acid. Endometria from nine women with unexplained menorrhagia synthesized more PGE2 than PGF 2 alpha, whereas the converse was true with 11 control endometria. Consequently the PGF2 alpha/PGE2 ratio was significantly reduced in the former group (p less than 0.025). Oestradiol-17 beta (200 microM) and to a greater extent 2 hydroxy oestradiol (200 microM) increased the total prostaglandin synthesis by the endometria, but did not significantly alter the PGF2 alpha/PGE2 ratio. These results suggest that excessive blood loss may be associated with a shift in the endometrial conversion of prostaglandin endoperoxide from PGF2 alpha to PGE2.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Dating the Endometrial Biopsy via openalex
- Levels of prostaglandins F2α and E2 in human endometrium during the menstrual cycle via openalex
- Levels of prostaglandins in human endometrium during the normal menstrual cycle via openalex
- Prostaglandin Content of Human Endometrium via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- SUPPRESSION OF CONCENTRATION OF ENDOMETRIAL PROSTAGLANDIN IN EARLY INTRA-UTERINE AND ECTOPIC PREGNANCY IN WOMEN via openalex
- W1981306007 via openalex
- W1988461890 via openalex
- W1994690142 via openalex
- W1996373986 via openalex
- W1997167805 via openalex
- W2000224985 via openalex
- W2012165536 via openalex
- W2018836477 via openalex
- W2033526345 via openalex
- W2040871036 via openalex
- W2040918473 via openalex
- W2041118356 via openalex
- W2045624175 via openalex
- W2051486326 via openalex
- W2058322868 via openalex
- W2068603512 via openalex
- W2083717098 via openalex
- W2089819304 via openalex
- W2094629461 via openalex
- W2097047879 via openalex
- W2122604012 via openalex
- W2148995162 via openalex
- W2170421901 via openalex
- W2418754503 via openalex
- W1574895695 via openalex
- W1967196000 via openalex
- W1967971455 via openalex
- W1970743286 via openalex
- W1978410153 via openalex
- W1978711334 via openalex
Cited by (50)
- Luteal phase oral dexamethasone administration alters the endometrial steroid milieu 2025
- Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding 2024
- From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Markers of human endometrial hypoxia can be detected <i>in vivo</i> and <i>ex vivo</i> during physiological menstruation 2021
- Obesity is associated with heavy menstruation that may be due to delayed endometrial repair 2021
- Effect of Tahiti lime (Citrus latifolia) juice on the Production of the PGF2α/PGE2 and Pro-Inflammatory Cytokines involved in Menstruation 2020
- Physiology of the Endometrium and Regulation of Menstruation 2020
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- Benign Uterine Diseases 2019
- Interventions for the treatment of heavy menstrual bleeding 2018
- Gynecology 2016
- Menstrual physiology: implications for endometrial pathology and beyond 2015
- A double blinded randomized controlled trial to compare Ormeloxifene and Norethisterone in the treatment of Dysfunctional Uterine Bleeding 2014
- A Novel Pilot Study of Endometrial Stromal Cells and Immune Cell Populations in Sentinel Uterine-Draining Lymph Nodes During the Menstrual Cycle and in Endometriosis 2013
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
- Immunology of Normal and Abnormal Menstruation 2013
- The influence of the hormonal milieu on eicosanoid and cytokine production in tissues from the female reproductive tract 2012
- The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? 2012
- Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety 2012
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age 2011
- Progesterone: a pivotal hormone at menstruation 2011
- Role of Non-Steroidal Anti-Inflammatory Drugs in Gynecology 2010
- Cortisol Inactivation by 11β-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation 2009
- Non-contraceptive health benefits of oral contraceptives 2008
- Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation 2007
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 2007
- Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia 2006
- Endocrine Regulation of Menstruation 2005
- Endocrine Regulation of Menstruation 2005
- Medical management of menstrual disorders 2004
- Medical management of dysfunctional uterine bleeding 2003
- Dysfunctional uterine bleeding: advances in diagnosis and treatment 2001
- Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women 2000
- Medical management of dysfunctional uterine bleeding 1999
- Abnormal uterine bleeding in the reproductive years. Part I—Pathogenesis and clinical investigation 1999
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 1998
- Dysfunctional uterine bleeding. 1998
- Medical Management of Menorrhagia in Pre- and Perimenopausal Women 1997
- Perimenopausal Dysfunctional Uterine Bleeding: Physiology and Management 1997
- Does endometrial resection help dysmenorrhea? 1997
- Prostaglandins and menstruation 1996
- Menorrhagia: a clinical update 1996
- Assessment of medical treatments for menorrhagia 1994
- Prostaglandin Synthesis Inhibitors in Menorrhagia, Intrauterine Contraceptive Device‐Induced Side Effects and Endometriosis 1994
- Nonsteroidal antiinflammatory drugs and reproduction 1993
- Investigation of menorrhagia 1992
- Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia 1992
- 8 Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders 1992
- Medical management of menorrhagia 1992
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK